BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2004
View Archived Issues
In vitro, in vivo and pharmacodynamic evaluations of Flt-3/KDR inhibitor
Read More
Telbivudine reported more effective than lamivudine in chronic hepatitis B
Read More
Different mechanisms suggested for HCV resistance to VX-950 and BILN-2061
Read More
Low incidence of anemia found with viramidine/pegylated interferon alfa-2a in HCV-infected patients
Read More
Therapeutic benefits of Alzhemed(TM) in patients with mild Alzheimer's disease
Read More
Evidence for cognitive improvement associated with phenserine in Alzheimer's disease
Read More
NCX-8001 reduces pain-like behavior in two rat models of neuropathic pain
Read More
Dual ACE/neural endopeptidase inhibitor AVE-7688 ameliorates diabetic nephropathy in obese ZDF rats
Read More
Glycopeptide antibiotics with antiviral activity prepared and tested at K.U. Leuven
Read More
Two series of HNE inhibitors prepared and tested by Bayer scientists
Read More
Novel Raf kinase inhibitors under study at Merck KGaA
Read More
New oxytocin inhibitors with potential in premature ejaculation treatment
Read More
New PPAR agonists for type 2 diabetes claimed by Merck
Read More
Kosan presents erythromycin-based motilin agonists
Read More
Adenosine deaminase inhibitors effective against inflammation and leukemia in vivo
Read More
Highly potent nociceptin/orphanin FQ peptide receptor agonist
Read More
Pariet approved in E.U. for on-demand GERD therapy
Read More
BioMarin to acquire Medicis' pediatric business
Read More
Proscar therapy approved to reduce risk of BPH symptom progression
Read More
Nycomed to develop and market Preos in Europe
Read More
Improved pharmacokinetics, antitumor activity and tolerability for liposomal vinorelbine
Read More
Elan licenses NanoCrystal technology to Roche
Read More
BTG licenses abiraterone acetate rights to Cougar
Read More
Inflazyme completes acquisition of Adprotech
Read More
New pilot trial studies Incert-S antiadhesion therapy
Read More
MedImmune and Cerus to codevelop novel therapeutic vaccine
Read More
Oxford BioMedica reviews Q1 progress
Read More
CG-53135 enters new phase I trial in bone marrow transplant patients
Read More
Advexin subject of new SWOG phase II trial
Read More
Dynport completes preclinical testing of recombinant plague vaccine
Read More
Gatiflo eye drops receive Japanese approval
Read More
Preclinical and clinical evidence for the benefits of IDN-6556 in liver disorders
Read More
Antiviral effects of NM-283 in chronic hepatitis C patients
Read More